Source: Annual Congress 2008 - Organisation of care and management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Chmielowicz, B. Panaszek, A. Obojski (Wroclaw, Poland). The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease). Eur Respir J 2008; 32: Suppl. 52, 3321

Member's Comments

No comment yet.

Related content which might interest you: Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Calorie-intake in patients hospitalized for an acute COPD exacerbation Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer Year: 2007 Impact of anemia in patients admitted due to a chronic obstructive pulmonary disease (COPD) exacerbation. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Prevelance of anemia in patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Pulmonary rehabilitation and its effect on exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention Year: 2005 A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Active smoking negatively affects recovery of patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions Year: 2011 7 Years survival of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 211s Year: 2001 The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007 Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007 Severity assessment in acute exacerbations of COPD Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005 Breathlessness during exacerbation of chronic obstructive pulmonary disease (ECOPD) and recovery Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications Year: 2019 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Prevalence of chronic rhinosinusitis in COPD stable patients Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 89s Year: 2002 Safety of early supported discharge in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) and low oxygen Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005